These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 9687419)
1. Active efflux of norfloxacin by Bacteroides fragilis. Miyamae S; Nikaido H; Tanaka Y; Yoshimura F Antimicrob Agents Chemother; 1998 Aug; 42(8):2119-21. PubMed ID: 9687419 [TBL] [Abstract][Full Text] [Related]
2. Evidence for active drug efflux in fluoroquinolone resistance in Clostridium hathewayi. Rafii F; Park M; Wynne R Chemotherapy; 2005 Aug; 51(5):256-62. PubMed ID: 16088123 [TBL] [Abstract][Full Text] [Related]
3. Hydrophilicity of quinolones is not an exclusive factor for decreased activity in efflux-mediated resistant mutants of Staphylococcus aureus. Takenouchi T; Tabata F; Iwata Y; Hanzawa H; Sugawara M; Ohya S Antimicrob Agents Chemother; 1996 Aug; 40(8):1835-42. PubMed ID: 8843290 [TBL] [Abstract][Full Text] [Related]
4. Quinolone resistance mediated by norA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome. Ng EY; Trucksis M; Hooper DC Antimicrob Agents Chemother; 1994 Jun; 38(6):1345-55. PubMed ID: 8092836 [TBL] [Abstract][Full Text] [Related]
5. Sixteen homologs of the mex-type multidrug resistance efflux pump in Bacteroides fragilis. Ueda O; Wexler HM; Hirai K; Shibata Y; Yoshimura F; Fujimura S Antimicrob Agents Chemother; 2005 Jul; 49(7):2807-15. PubMed ID: 15980353 [TBL] [Abstract][Full Text] [Related]
6. Comparison of rufloxacin and norfloxacin effects on faecal flora. Marco F; Giménez MJ; Jiménez de Anta MT; Marcos MA; Salvá P; Aguilar L J Antimicrob Chemother; 1995 Jun; 35(6):895-901. PubMed ID: 7559202 [TBL] [Abstract][Full Text] [Related]
7. BmeRABC5 is a multidrug efflux system that can confer metronidazole resistance in Bacteroides fragilis. Pumbwe L; Chang A; Smith RL; Wexler HM Microb Drug Resist; 2007; 13(2):96-101. PubMed ID: 17650960 [TBL] [Abstract][Full Text] [Related]
8. Uptake of sparfloxacin and norfloxacin by clinical isolates of Staphylococcus aureus. Yoshida S; Kojima T; Inoue M; Mitsuhashi S Antimicrob Agents Chemother; 1991 Feb; 35(2):368-70. PubMed ID: 2024969 [TBL] [Abstract][Full Text] [Related]
9. Accumulation of garenoxacin by Bacteroides fragilis compared with that of five fluoroquinolones. Ricci V; Piddock L J Antimicrob Chemother; 2003 Oct; 52(4):605-9. PubMed ID: 12951329 [TBL] [Abstract][Full Text] [Related]
10. The role of efflux pumps in Bacteroides fragilis resistance to antibiotics. Ghotaslou R; Yekani M; Memar MY Microbiol Res; 2018 May; 210():1-5. PubMed ID: 29625653 [TBL] [Abstract][Full Text] [Related]
11. The effects of NorA inhibition on the activities of levofloxacin, ciprofloxacin and norfloxacin against two genetically related strains of Staphylococcus aureus in an in-vitro infection model. Aeschlimann JR; Kaatz GW; Rybak MJ J Antimicrob Chemother; 1999 Sep; 44(3):343-9. PubMed ID: 10511401 [TBL] [Abstract][Full Text] [Related]
12. [Accumulation and efflux of quinolones by clinical isolates of Stenotrophomonas maltophilia]. Sánchez P; Alonso A; Campanario E; Alós I; Martíinez JL Rev Esp Quimioter; 2000 Jun; 13(2):176-81. PubMed ID: 10918091 [TBL] [Abstract][Full Text] [Related]